• 10 WEST 2.42

Accepting PhD Students

If you made any changes in Pure these will be visible here soon.

Personal profile

Research interests

Tom is the Lead Director of the Addiction and Mental Health Group (AIM) within the Department of Psychology at the University of Bath. He is a Senior Academic Fellow of the Society for the Study of Addiction and a member of Council for the British Association for Psychopharmacology. Tom has given expert evidence to the National Institute of Health and Care Excellence (NICE) and commissioned projects for the European Union drugs agency. He is an Associate Editor for the journal Addiction. He holds honorary appointments at the National Addiction Centre at King’s College London and the Clinical Psychopharmacology Unit at UCL.

Tom uses interdisciplinary research methods to investigate the aetiology and treatment of addiction and mental health disorders. These include observational methods to characterise changes in drug products and their relationship to health, experimental studies to probe neurocognitive and biological mechanisms, and clinical trials to evaluate novel interventions. His current interests include transitions in global cannabis markets, the role of cannabinoids as causes and cures for addiction and mental health disorders, and identfying vulnerability and resilience factors to improve treatment, prevention and harm reduction.

Fingerprint Dive into the research topics where Tom Freeman is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 13 Similar Profiles
Cannabis Medicine & Life Sciences
Cannabidiol Medicine & Life Sciences
Reward Medicine & Life Sciences
Dronabinol Medicine & Life Sciences
Pharmaceutical Preparations Medicine & Life Sciences
Tobacco Medicine & Life Sciences
Cannabinoids Medicine & Life Sciences
Smoking Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2009 2019

1 Citation (Scopus)

Acute effects of cannabinoids on addiction endophenotypes are moderated by genes encoding the CB1 receptor and FAAH enzyme

Hindocha, C., Freeman, T. P., Schafer, G., Gardner, C., Bloomfield, M. A. P., Bramon, E., Morgan, C. J. A. & Curran, H. V., 23 Apr 2019, In : Addiction Biology. e12762.

Research output: Contribution to journalArticle

1 Citation (Scopus)
26 Downloads (Pure)

Changes in the composition of cannabis from 2000-2017 in Denmark: Analysis of confiscated samples of cannabis resin

Thomsen, K. R., Lindholst, C., Thylstrup, B., Kvamme, S., Reitzel, L. A., Worm-Leonhard, M., Englund, A., Freeman, T. P. & Hesse, M., 1 Aug 2019, In : Experimental and Clinical Psychopharmacology. 27, 4, p. 402-411 10 p.

Research output: Contribution to journalArticle

Open Access
18 Downloads (Pure)
Open Access
7 Citations (Scopus)
9 Downloads (Pure)

Dissociable effects of cannabis with and without cannabidiol on the human brain’s resting-state functional connectivity

Wall, M. B., Pope, R., Freeman, T. P., Kowalczyk, O. S., Demetriou, L., Mokrysz, C., Hindocha, C., Lawn, W., Bloomfield, M. A. P., Freeman, A. M., Feilding, A., Nutt, D. J. & Curran, H. V., 1 Jul 2019, In : Journal of Psychopharmacology. 33, 7, p. 822-830 9 p.

Research output: Contribution to journalArticle

Open Access